Robert G. Davidson

Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.

Fergus McTaggart, Linda K. Buckett, Robert G. Davidson et al. · The American Journal of Cardiology · 2001 · 412 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +12

Inhibitors of 3-Hydroxy-3-Methylglutaryl–CoA Reductase Reduce Receptor-Mediated Endocytosis in Opossum Kidney Cells

James E. Sidaway, Robert G. Davidson, Fergus McTaggart et al. · Journal of the American Society of Nephrology · 2004 · 156 citations

Albumin Uptake, Cytoskeleton, Nephrology +21

Hematological Changes Associated with Marathon Running

Robert G. Davidson, Janet Robertson, Gabriel L. Galea et al. · International Journal of Sports Medicine · 1987 · 112 citations

Identification of an Alveolar Macrophage-derived Activity in Bronchial Asthma that Enhances Leukotriene C ₄ Generation by Human Eosinophils Stimulated by lonophore A23187 as a Granulocyte-macrophage Colony-stimulating Factor

C. J. Howell, J-L. Pujol, Attilio Crea et al. · American Review of Respiratory Disease · 1989 · 94 citations

Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability

Christophe Furman, Corinne Copin, Mejid Kandoussi et al. · Atherosclerosis · 2004 · 85 citations

Inflammation, Cytokine, Human Monocyte-derived Macrophages +13